Evidence map›Paper›PMID 40439456›Full record

ArticleEmerging infectious diseases2025

OXA-204 Carbapenemase in Clinical Isolate of Pseudomonas guariconensis, Tunisia.

Nadia Jaidane, Wejdene Mansour, Lamia Tilouche, Pierre Châtre, Pauline François, Agnese Lupo, Saoussen Oueslati, Aymeric Jacquemin, Ali Lazzem, Sonia Karaborni and 7 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Characterization of GUA-1, a chromosomally encoded ESBL fromAntimicrobial agents and chemotherapy · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Nadia Jaidane
Wejdene Mansour
Lamia Tilouche
Pierre Châtre
Pauline François
Agnese Lupo
Saoussen Oueslati
Aymeric Jacquemin
Ali Lazzem
Sonia Karaborni
Laetitia Du Fraysseix
Yomna Ben Lamine
Nidhal Mahdhi
Abdelhalim Trabelsi
Jean-Yves Madec
Marisa Haenni
Thierry Naas

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report an OXA-204-producing Pseudomonas guariconensis clinical isolate in Tunisia, proving the spread of OXA-48 variants beyond Enterobacterales. The bla

Indexed as

Bacterial Proteinsbeta-LactamasesPseudomonasPseudomonas InfectionsAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsPlasmidsTunisiaAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemaseantimicrobial resistancebacteriabacterial infectionburn unitcarbapenemaseCMY-16Enterobacteralesmultidrug resistanceOXA-204Pseudomonas guariconensisTunisia

Identifiers

PMID40439456
PMCPMC12123930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.